Protein-protein interaction ( PPI ) network and significant gene analysis of breast cancer

The incidence of breast cancer is one of the highest female malignant tumors. While, the early diagnosis and treatment of breast cancer with microarray technology are requisite in breast cancer research. We aimed to identify new potential signaling pathways and key genes in breast cancer. The transcription profile of GSE54002 was downloaded from Gene Expression Omnibus (GEO) database, including 417 breast cancer and 16 healthy samples. The differentially expressed genes (DEGs) between cancer and healthy group were screened with non-paired t-test and analyzed by Cluster 3.0 software. We used the DAVID online tools to enrich the Gene Ontology function and the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway of significantly upand down-regulated genes. After construction of interaction network of proteins encoded by DEGs, the topological properties of networks and function modules were analyzed with Cytoscape. A total of 789 DEGs were identified in breast cancer samples compared to normal tissue samples, including 257 up-regulated and 532 down-regulated genes. In GO terms, the up-regulated genes are mainly related with cell cycle and interaction of extracellular matrix; While in KEGG pathways, up-regulated genes were enriched in cell cycle pathway and ECM-receptor interaction pathway. In addition, the transcription factor FOS and its multiple downstream regulatory factors were highly expressed in cancer tissue. The discovery of the DEGs with high expression in enrichment analysis might help understand the mechanism of breast cancer. Moreover, the key factors we predicted in development of breast cancer could provide references for the diagnosis and treatment of this disease.

[1]  Jorge S Reis-Filho,et al.  The contribution of gene expression profiling to breast cancer classification, prognostication and prediction: a retrospective of the last decade , 2010, The Journal of pathology.

[2]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[3]  G. Enders Expanded Roles for Chk1 in Genome Maintenance* , 2008, Journal of Biological Chemistry.

[4]  Damian Szklarczyk,et al.  The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored , 2010, Nucleic Acids Res..

[5]  S. Weroha,et al.  Dual HER/VEGF Receptor Targeting Inhibits In Vivo Ovarian Cancer Tumor Growth , 2013, Molecular Cancer Therapeutics.

[6]  Dong Ryul Lee,et al.  The Novel miR-7515 Decreases the Proliferation and Migration of Human Lung Cancer Cells by Targeting c-Met , 2012, Molecular Cancer Research.

[7]  B. Zhu,et al.  Role of Cyclin B1/Cdc2 Up-Regulation in the Development of Mitotic Prometaphase Arrest in Human Breast Cancer Cells Treated with Nocodazole , 2011, PloS one.

[8]  M. Baggiolini,et al.  Interleukin-8 and the chemokine family. , 1995, International journal of immunopharmacology.

[9]  F. Grosse,et al.  Human Cdc45 is a proliferation‐associated antigen , 2007, The FEBS journal.

[10]  Richard D Kolodner,et al.  An overview of Cdk1-controlled targets and processes , 2010, Cell Division.

[11]  T. Yeatman,et al.  Novel Molecular Markers of Malignancy in Histologically Normal and Benign Breast , 2011, Pathology research international.

[12]  M. Roizen,et al.  Hallmarks of Cancer: The Next Generation , 2012 .

[13]  Randall Harris Cyclooxygenase-2 (cox-2) and the inflammogenesis of cancer. , 2007, Sub-cellular biochemistry.

[14]  M. Frommer,et al.  Role of radiotherapy in cancer control in low-income and middle-income countries. , 2006, The Lancet. Oncology.

[15]  L. Penland,et al.  Use of a cDNA microarray to analyse gene expression patterns in human cancer , 1996, Nature Genetics.

[16]  K L Gould,et al.  Regulating the onset of mitosis. , 1999, Current opinion in cell biology.

[17]  Anthony Howell The emerging breast cancer epidemic: early diagnosis and treatment , 2010, Breast Cancer Research.

[18]  M. Martinka,et al.  Aberrant Expression of Collagen Triple Helix Repeat Containing 1 in Human Solid Cancers , 2006, Clinical Cancer Research.

[19]  Benjamin M. Bolstad,et al.  affy - analysis of Affymetrix GeneChip data at the probe level , 2004, Bioinform..

[20]  Mitch Dowsett,et al.  Emerging Biomarkers and New Understanding of Traditional Markers in Personalized Therapy for Breast Cancer , 2008, Clinical Cancer Research.

[21]  Brad T. Sherman,et al.  DAVID: Database for Annotation, Visualization, and Integrated Discovery , 2003, Genome Biology.

[22]  M. Burdick,et al.  Cancer CXC chemokine networks and tumour angiogenesis. , 2006, European journal of cancer.

[23]  F. Cross,et al.  Regulated degradation of the APC coactivator Cdc20 , 2010, Cell Division.

[24]  Qing Yang,et al.  Screening of feature genes of the ovarian cancer epithelia with DNA microarray , 2013, Journal of Ovarian Research.

[25]  Michael Kohl,et al.  Cytoscape: software for visualization and analysis of biological networks. , 2011, Methods in molecular biology.

[26]  T. Halazonetis,et al.  Genomic instability — an evolving hallmark of cancer , 2010, Nature Reviews Molecular Cell Biology.

[27]  Kahn Rhrissorrakrai,et al.  MINE: Module Identification in Networks , 2011, BMC Bioinformatics.

[28]  Ying Lin,et al.  Interleukin‐8 modulates growth and invasiveness of estrogen receptor‐negative breast cancer cells , 2007, International journal of cancer.

[29]  T. Tan,et al.  Epithelial-mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients , 2014, EMBO molecular medicine.

[30]  C. Shriver,et al.  Molecular response of the axillary lymph node microenvironment to metastatic colonization , 2014, Clinical & Experimental Metastasis.

[31]  Haiyang Xie,et al.  Characterization of genome-wide TFCP2 targets in hepatocellular carcinoma: implication of targets FN1 and TJP1 in metastasis , 2015, Journal of Experimental & Clinical Cancer Research.

[32]  Xinguo Jiang,et al.  The immune system and inflammation in breast cancer , 2014, Molecular and Cellular Endocrinology.

[33]  Yue Xiong,et al.  p15PAF, a novel PCNA associated factor with increased expression in tumor tissues , 2001, Oncogene.

[34]  F. Jänicke,et al.  C-Fos expression is a molecular predictor of progression and survival in epithelial ovarian carcinoma , 2008, British Journal of Cancer.

[35]  R. Sinha,et al.  Opportunities for cancer epidemiology in developing countries , 2004, Nature Reviews Cancer.

[36]  T. Poggio,et al.  Multiclass cancer diagnosis using tumor gene expression signatures , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[37]  Byong Hoon Yoo,et al.  Progesterone-Inducible Cytokeratin 5-Positive Cells in Luminal Breast Cancer Exhibit Progenitor Properties , 2013, Hormones and Cancer.

[38]  B. Casto,et al.  Cyclooxygenase-2 and the inflammogenesis of breast cancer. , 2014, World journal of clinical oncology.

[39]  P. Hoff,et al.  Serum protein profiling reveals baseline and pharmacodynamic biomarker signatures associated with clinical outcome in mCRC patients treated with chemotherapy ± cediranib , 2014, British Journal of Cancer.

[40]  W. McGuire,et al.  Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. , 1987, Science.

[41]  Jiri Bartek,et al.  An Oncogene-Induced DNA Damage Model for Cancer Development , 2008, Science.

[42]  J. Li,et al.  Plk1 Phosphorylation of PTEN Causes a Tumor-Promoting Metabolic State , 2014, Molecular and Cellular Biology.

[43]  J. Julian Blow,et al.  Replication licensing and cancer — a fatal entanglement? , 2008, Nature Reviews Cancer.

[44]  M. Zabel,et al.  COX-2 expression pattern is related to ovarian cancer differentiation and prognosis, but is not consistent with new model of pathogenesis. , 2014, Ginekologia polska.

[45]  M. Blaser,et al.  Mechanisms of Disease: inflammation and the origins of cancer , 2005, Nature Clinical Practice Oncology.

[46]  Aristides G. Eliopoulos,et al.  Cdc6 expression represses E-cadherin transcription and activates adjacent replication origins , 2011, The Journal of cell biology.

[47]  Tsung-Hsien Chang,et al.  Ubiquitin-Conjugating Enzyme UBE2C Is Highly Expressed in Breast Microcalcification Lesions , 2014, PloS one.